Antidepressants and Dementia: Increased Mortality Risk Revealed in New Study

A recent study from Queen’s University Belfast suggests a concerning link between the utilize of antidepressants and anti-anxiety medications and an increased risk of death for individuals diagnosed with dementia. The research highlights the need for careful consideration when prescribing these medications to patients with cognitive decline.

Study Findings: A Closer Look

Researchers from the School of Pharmacy and Centre for Public Health at Queen’s University Belfast analyzed data from 28,781 people living with dementia in Northern Ireland over a nine-year period (2012-2020). The study, published in Antidepressant and anxiolytic medications and risk of mortality in people with dementia, found that approximately half of the participants died during the follow-up period.

The findings revealed that antidepressants were prescribed to 59.2% of those who died, while 44.8% were prescribed anti-anxiety medications. Statistical analysis indicated a weak increased risk of mortality among dementia patients prescribed antidepressants, and a significantly stronger increased risk for those prescribed anti-anxiety medications. Specifically, the adjusted odds ratio for mortality was 1.08 for antidepressants (95% CI 1.02-1.14) and 1.26 for anxiolytics (95% CI 1.19-1.33).

Why This Matters: The Growing Dementia Crisis

Dementia is a major global health challenge, affecting over 55 million people worldwide, with an estimated 10 million new cases diagnosed each year. As the global population ages, the prevalence of dementia is projected to continue to rise. Currently, there is no effective treatment to cure dementia, making the management of symptoms and quality of life crucial.

Dr. Catherine Sinnamon, lead author of the research, emphasized the importance of optimizing health and quality of life for individuals with dementia while minimizing social and economic costs. “People living with dementia often have other medical conditions which means that they are prescribed multiple medications,” she stated. “Sometimes these medicines may not always be appropriate.”

Implications for Prescribing Practices

The study underscores the critical need for regular and thorough medication reviews for individuals with dementia. Healthcare professionals, including GPs and pharmacists, should ensure that prescribed medications remain appropriate and necessary. Heather Barry, a principal investigator on the study, noted that the findings “extend our knowledge and highlight the importance of judicious prescribing for people with dementia.”

Research also suggests a potential link between antidepressant use and an increased risk of dementia in older adults generally. A retrospective cohort study found an association between first-line antidepressant use and dementia risk, although further research is needed to fully understand this relationship.

Key Takeaways

• A Queen’s University Belfast study found an increased risk of death for dementia patients taking antidepressants or anti-anxiety medications.
• The risk was more pronounced with anti-anxiety medications compared to antidepressants.
• Regular medication reviews are crucial for dementia patients to ensure appropriate prescribing.
• Dementia affects over 55 million people globally, and its prevalence is increasing.

This research serves as a vital reminder of the complexities of managing dementia and the importance of a personalized, cautious approach to medication use in this vulnerable population.